MedTrace Logo

Prevention of Cervical Cancer Through an HPV-based Screen-and-treat Strategy in Malawi

NCT04286243 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8174

Last updated 2023-11-07

No results posted yet for this study

Summary

The purpose of the study is to determine the acceptability, appropriateness, and feasibility of implementing new strategies to screen and treat eligible women for cervical cancer through a cluster randomized trial of two different models. Both models offer the same screening and treatment algorithm, but one will be based in Voluntary Family Planning (VFP) or other clinics and the second will be based in the community. Participants will be recruited from two districts in Malawi with the highest HIV prevalence in the country: Lilongwe in the Central Region and Zomba in the Southern Region.

Conditions

Interventions

OTHER

Community-based HPV screening strategy

Offering HPV self-collection for cervical cancer screening in the community

OTHER

Clinic-based HPV screening strategy

Offering HPV self-collection for cervical cancer screening in the clinic

Sponsors & Collaborators

  • United States Agency for International Development (USAID)

    collaborator FED

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Jennifer Tang, MD, MSCR · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-04
Primary Completion
2021-12-18
Completion
2021-12-18

Countries

  • Malawi

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04286243 on ClinicalTrials.gov